|
|
||||||||
* These authors contributed equally to this work.
Address correspondence and reprint requests to Dr. Valerie Askanas, USC Neuromuscular Center, Good Samaritan Hospital, 637 S. Lucas Ave, Los Angeles, CA 90017-1912; e-mail: askanas{at}hsc.usc.edu
Background: An important aspect of inclusion-body myositis (IBM) vacuolated muscle fibers (VMF) is abnormal accumulation of amyloid-ß precursor protein (AßPP) epitopes and its product, amyloid-ß (Aß), and of phosphorylated tau (p-tau) in the form of paired helical filaments. Lipoprotein receptors and cholesterol are known to play an important role in AßPP processing, Aß production, and tau phosphorylation.
Methods: In 10 IBM and 22 control muscle biopsies the authors immunolocalized low-density lipoprotein receptor (LDLR), very low-density lipoprotein receptor (VLDLR), and low-density lipoprotein receptor-related protein (LRP), and colocalized them with Aß, p-tau, APOE, and free cholesterol.
Results: In each biopsy, virtually all IBM VMF had strong LDLR-immunoreactive inclusions, which colocalized with Aß, APOE, p-tau, and free cholesterol. VLDLR was increased mainly diffusely, but in approximately 50% of the VMF it was also accumulated in the form of inclusions colocalizing with Aß, APOE, and free cholesterol, but not with p-tau. LRP inclusions were present in a few VMF. In all myopathies, a subset of regenerating and necrotizing muscle fibers had prominent diffuse accumulation of both LDLR and free cholesterol. At normal neuromuscular junctions (NMJ) postsynaptically, LDLR and VLDLR, but not LRP, were immunoreactive.
Conclusions: 1) Abnormal accumulation of LDLR, VLDLR, LRP, and cholesterol within IBM vacuolated muscle fibers suggests novel roles for them in the IBM pathogenesis. 2) Expression of LDLR and VLDLR at normal NMJ suggests physiologic roles for them in transsynaptic signaling pathways, increased internalization of lipoproteins there, or both. 3) Increased LDLR and free cholesterol in some regenerating and necrotizing muscle fibers suggest a role for them in human muscle fiber growth and repair and necrotic death.
This article has been cited by other articles:
![]() |
X. Chen, O. Ghribi, and J. D. Geiger Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R829 - R835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang Apolipoprotein E and Alzheimer disease Neurology, January 24, 2006; 66(1_suppl_1): S79 - S85. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Vetrivel and G. Thinakaran Amyloidogenic processing of {beta}-amyloid precursor protein in intracellular compartments Neurology, January 24, 2006; 66(1_suppl_1): S69 - S73. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Askanas and W. K. Engel Inclusion-body myositis: A myodegenerative conformational disorder associated with A{beta}, protein misfolding, and proteasome inhibition Neurology, January 24, 2006; 66(1_suppl_1): S39 - S48. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Askanas and W. King Engel Unfolding Story of Inclusion-Body Myositis and Myopathies: Role of Misfolded Proteins, Amyloid-{beta}, Cholesterol, and Aging J Child Neurol, March 1, 2003; 18(3): 185 - 190. [Abstract] [PDF] |
||||
![]() |
S. A. Greenberg, D. Sanoudou, J. N. Haslett, I. S. Kohane, L. M. Kunkel, A. H. Beggs, and A. A. Amato Molecular profiles of inflammatory myopathies Neurology, October 22, 2002; 59(8): 1170 - 1182. [Abstract] [Full Text] [PDF] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |